Beam Therapeutics · 1 month ago
Sr. Director, QC Analytical Methods
Durham, NC
Full-time
Onsite
Director/Executive
$250K/yr - $310K/yr
18+ years expBeam Therapeutics is a biotechnology company committed to establishing a leading platform for precision genetic medicines. The Sr. Director, Quality Control, Analytical Methods will provide strategic leadership to Quality Control teams, overseeing the lifecycle management of analytical methods and ensuring compliance with regulatory guidelines.
BiotechnologyGeneticsMedicalTherapeutics
Responsibilities
Deliver comprehensive Quality Control leadership across multiple programs and cross-functional forums
Develop and implement robust QC strategies for method qualification, transfer, and validation in collaboration with Analytical Development and other key stakeholders (e.g., Product Quality Leads)
Provide strategic direction to Quality Control teams in North Carolina and Massachusetts, ensuring excellence in method lifecycle management and product quality testing and stability
Serve as a QC leader in interactions with Beam’s suppliers (e.g., CMOs/CTLs) and the internal manufacturing site in Durham, North Carolina
Establish and monitor metrics for all testing aspects, including in-process, release, stability testing, and OOT/OOS results
Partner with Quality Assurance to ensure contract laboratory service providers are appropriately qualified and that Quality Agreements are comprehensive, approved, and regularly updated
Ensure strict adherence to GMP principles within internal and external laboratories
Maintain compliance of quality control systems and equipment with all applicable regulatory guidelines, upholding data integrity to ensure confidence in generated data
Track and analyze GMP data, including the evaluation and approval of data from external contract laboratories
Compile and present data with insightful interpretations for management reviews, Annual Product Reviews, and other required assessments
Drive continuous improvement initiatives across the Quality Control Group
Qualification
Required
Bachelor's or advanced degree in scientific discipline
Minimum of 18 years' experience in the pharmaceutical/biotech industry, encompassing drug substance/drug product manufacturing, development, and/or quality. Direct experience with cell and/or gene therapy programs is strongly preferred
Experience with implementing, validating, and overseeing execution of automated test methods
Proven experience leading teams in Quality and Quality Control functions
Demonstrated support for all phases of a program's lifecycle (pre-IND through commercial lifecycle management)
At least 10 years of Quality management experience
Exceptional verbal and written communication skills, with a detail-oriented approach and the ability to drive change across functions
Experience engaging with regulatory health authorities during pre- and post-approval inspections
In-depth knowledge of global regulations and standards
Collaborative team player with a customer service mindset and solution-oriented approach
Strong attention to detail and ability to work independently, within multidisciplinary teams, and with external partners and vendors
Outstanding team building, leadership, and management skills
Excellent listening, communication, and interpersonal skills that foster team spirit
Consistent delivery of high-quality work
Superior skills in managing vendors and stakeholders involved in Quality and Regulatory activities to achieve corporate objectives
Strong team player that has a customer service approach and is solution oriented
Must be able to work onsite daily and willing to have a flexible schedule during peak times, which may include supporting critical operations outside of normal work hours, as needed
Company
Beam Therapeutics
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.
501-1000 employees
H1B Sponsorship
Beam Therapeutics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (11)
2024 (9)
2023 (12)
2022 (9)
2021 (7)
2020 (4)
Funding
Current Stage
Public CompanyTotal Funding
$1.19B2025-03-10Post Ipo Equity· $500M
2021-01-19Post Ipo Equity· $260M
2020-02-11Post Ipo Equity· $207M
Leadership Team
John Evans
CEO
Christine Bellon
Chief Legal Officer
Recent News
2026-01-23
2026-01-13
Company data provided by crunchbase